View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Febuxostat 120, Prevention of Tumor Lysis Syndrome in Patients at Moderate Risk
Protocol-ID: 3259 V1.0 (Mini), FEBU120, Tumor Lysis Syndrome Prevention, Moderate RiskIndication(s)
- Tumor Lysis Syndrome; ICD-10 E88.3
Links
- Tumor Lysis Syndrome (TLS) in Adult Patients (MD Anderson, 2025) [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 06.10.2026